Expand DYN Menu
DYN MENU

Dyne Therapeutics (DYN) closed at $16.02 on November 17, 2026, down 4.1% from the previous close, on volume of 1,973,764 shares (30-day average 2,588,028).

Key numbers
  • Last close: $16.02 (November 17, 2026)
  • 52-week range: $14.00 to $27.31
  • Market value: $3.0 billion
  • 30-day implied volatility (IV30): 51.8%
  • Option volume: 63 contracts (57 calls, 6 puts); 30-day average 1,004

Data as of November 17, 2026.

DYN Stock Summary and Trading Ideas (Dyne Therapeutics | NASDAQ:DYN)

Charts for Today's Stock Price and Implied Volatility in Dyne Therapeutics

17-Nov-2026

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for DYN by Theoretical Edge and Win Rates

Sentiment

Largest Multi-Leg Option Trades (30 Days)

#DateStrategyLegsContracts
1 Oct 19, 2026 Calendar Call Spread 18-Dec-26 : 19-Mar-27 20 C 2,002
2-3 The next 2 largest trades are for Premium members. Start a 7-day free trial

Premium Feature

Login|Subscribe

Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 17, 2026. See the largest for 5, 30, 60 and 90 days

News

Trading Statistics

Key Ratios

Dyne Therapeutics (DYN) Frequently Asked Questions

What does Dyne Therapeutics do?

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

What symbol and exchange does Dyne Therapeutics shares trade?

Dyne Therapeutics trades on the NASDAQ stock market under the symbol DYN.

What is Dyne Therapeutics stock price doing today?

As of November 17, 2026, DYN stock price declined to $16.02 with 1,973,764 million shares trading.

What is Dyne Therapeutics's Beta?

DYN has a beta of 0.93, meaning it tends to be less sensitive to market movements. DYN has a correlation of 0.04 to the broad based SPY ETF.

How much is Dyne Therapeutics worth?

DYN has a market cap of $2.99 billion. This is considered a Mid Cap stock.

What is the highest and lowest price Dyne Therapeutics traded in the last 3 year period?

In the last 3 years, DYN traded as high as $47.45 and as low as $6.36.

What are the top ETFs holding Dyne Therapeutics?

The top ETF exchange traded funds that DYN belongs to (by Net Assets): VTI, XBI, IWM, VXF, VB.

Is Dyne Therapeutics (DYN) a good investment?

DYN has underperformed the market in the last year with a price return of -20.8% while the SPY ETF gained +10.1%. DYN has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -38.7% and -11.2%, respectively, while the SPY returned -5.4% and -2.6%, respectively.

What are the support and resistance levels for Dyne Therapeutics (DYN)?

DYN support price is $16.04 and resistance is $17.36 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DYN shares will trade within this expected range on the day.

Market Data Delayed 15 Minutes